| Autor: |
Khamkaew N; Department of Chemical Engineering, Faculty of Engineering, Chulalongkorn University, Bangkok 10330, Thailand.; Center of Excellence in Biomaterial Engineering in Medical and Health, Faculty of Engineering, Chulalongkorn University, Bangkok 10330, Thailand., Kanokpanont S; Department of Chemical Engineering, Faculty of Engineering, Chulalongkorn University, Bangkok 10330, Thailand.; Center of Excellence in Biomaterial Engineering in Medical and Health, Faculty of Engineering, Chulalongkorn University, Bangkok 10330, Thailand., Apinun J; Center of Excellence in Biomaterial Engineering in Medical and Health, Faculty of Engineering, Chulalongkorn University, Bangkok 10330, Thailand.; Department of Orthopaedics, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand., Wangdee C; Center of Excellence in Biomaterial Engineering in Medical and Health, Faculty of Engineering, Chulalongkorn University, Bangkok 10330, Thailand.; Department of Veterinary Surgery, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand., Motta A; BIOtech Research Center, Department of Industrial Engineering, University of Trento, 38123 Trento, Italy., Damrongsakkul S; Department of Chemical Engineering, Faculty of Engineering, Chulalongkorn University, Bangkok 10330, Thailand.; Center of Excellence in Biomaterial Engineering in Medical and Health, Faculty of Engineering, Chulalongkorn University, Bangkok 10330, Thailand. |
| Abstrakt: |
The porous particles prepared from composited calcium-ortho-phosphate (biphasic), Thai silk fibroin, gelatin, and alginate, with an organic to inorganic component ratio of 15.5:84.5, were tested for their abilities to control the release of the commercialized antibiotic solutions, clindamycin phosphate (CDP) and amikacin sulfate (AMK). The in vitro biodegradability tests complying to the ISO 10993-13:2010 standard showed that the particles degraded <20 wt% within 56 days. The drugs were loaded through a simple adsorption, with the maximum loading of injection-graded drug solution of 43.41 wt% for CDP, and 39.08 wt% for AMK. The release profiles from dissolution tests of the drug-loaded particles varied based on the adsorption methods used. The drug-loaded particles (without a drying step) released the drug immediately, while the drying process after the drug loading resulted in the sustained-release capability of the particles. The model-fitting of drug release profiles showed the release driven by diffusion with the first-ordered kinetic after the initial burst release. The released CDF and AMK from particles could sustain the inhibition of Gram-positive bacteria and Gram-negative bacteria, respectively, for at least 72 h. These results indicated the potential of these composited particles as controlled-release carriers for CDP and AMK. |
